Navigation Links
PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer
Date:2/24/2009

MOUNTAIN VIEW, Calif., Feb. 24 /PRNewswire/ -- PolyRemedy, Inc., a manufacturer of point-of-care robotic systems for the fabrication and tracking of customized, nano-material-based wound treatments, has hired Jeffrey S. Jones to serve as the Company's chief operating officer (COO). Jones, a seasoned healthcare executive, joined the PolyRemedy management team in January 2009.

"With his experience in growing innovative medical device companies, Jeff brings a proven track record of driving change and achieving results in high growth environments," says Dan Eckert, president and chief executive officer of PolyRemedy. "With a national priority on reducing healthcare costs while improving the quality of care, the timing is great for us to introduce an evidence-driven wound care treatment system, and we are thrilled to have Jeff's experience and leadership on our team as we continue to build our company."

"PolyRemedy's expertise in providing customized wound treatments with objective wound care information is truly unique. We have a real opportunity to improve wound care outcomes," Jones says. "I look forward to working with everyone at PolyRemedy to deliver our innovative wound care treatment approach to the market." As COO, Jones is responsible for managing all aspects of PolyRemedy operations, including manufacturing, research and development, product engineering, software development, information technology, quality assurance, regulatory, materials, purchasing, customer and field service.

Prior to joining PolyRemedy, Jones served as COO at Reliant Technologies, a medical device company in Mountain View, Calif., that developed and launched the innovative Fraxel Laser for skin resurfacing. While there, Jones built strong operations, product engineering, regulatory, quality assurance and an in-house medical clinic to support product launches. By the time Reliant was acquired by Solta Medical in 2008, Jones had helped to grow the company revenue to an $88 million annual run rate.

Previously, Jones was COO at LuMend, Inc., Redwood City, Calif., an interventional cardiology medical device company and vice president of operations at EP Technologies, a subsidiary of Boston Scientific Corporation, San Jose, Calif., an interventional cardiology medical device company. Earlier in his career, Jones held various management positions, including director of Fiber Products Group at Coherent Inc., Palo Alto, Calif., a medical laser system company, and manager of Test and Test Engineering at Hughes Aircraft Company, Fullerton, Calif. Jones was also a captain in the U.S. Army.

Jones received a bachelor's degree in engineering from the United States Military Academy, West Point, NY, and an MBA from Golden Gate University, San Francisco.

About PolyRemedy

PolyRemedy, based in Mountain View, Calif., manufactures robotic systems for the fabrication of nano-fiber wound treatments, on demand and at the point of care. The innovative PolyRemedy system produces customized wound dressings within minutes, measured to fit the wound size and shape and fabricated with the precise material composition necessary to optimally treat the wound. The system also captures and monitors important wound treatment data with the potential to help evaluate costs, refine clinical protocols, and demonstrate evidence-based improvements in wound management.


'/>"/>
SOURCE PolyRemedy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PolyRemedy Hires Gary Coughlen as CFO
2. PolyRemedy Strengthens Executive Team With Additions of Diane Cooper, PhD, and Joe Coyne
3. Digirad Names Richard B. Slansky Chief Financial Officer
4. Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman
5. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
6. maxIT Healthcare Names David H. Tucker as National Accounts Business Director
7. Innerscope Research(TM) Names Caleb Siefert as Senior Scientist to Lead Companys Statistical Analyses and Study Designs
8. S.C.-Based Technology Consortium Names Interim Executive Director and Board
9. NHP Names New Chairman and Lead Independent Director
10. The SCAN Foundation Names New Members to Its Board
11. JNCCN Names New Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford ... this week. A group of researchers and leaders from Sanford Health were selected ... Medicine and Its Cultural Impact ” and receive the 2016 Pontifical Key Innovation ...
(Date:4/28/2016)... ... April 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, ... The competition will be held at the University of Montana on April 28-May 1. ... the Mississippi River. , In order to qualify, Varize needed to place top seven ...
(Date:4/28/2016)... Angeles, CA (PRWEB) , ... April 28, 2016 , ... ... on its website, cosmetictown.com . The forum section was recently revamped and upgraded ... the latest surgical techniques in use across the country. , According to the senior ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine named ... emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues that ... is also the Founder of BionX , a leader in the field of ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore ... This is unfortunately true. But we toss the baby out with the bathwater when ... provides tips for identifying higher-quality studies and otherwise making better use of education policy ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- TapImmune,Inc. (TPIV), a clinical-stage immune-oncology ... immunotherapeutics and vaccines for the treatment of cancer & metastatic ... Annual Growth Capital Expo to be held on May ... Palace in Las Vegas, Nevada.  The Company presentation will ... by Dr. John N. Bonfiglio a TapImmune ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology: